Reunion Neuroscience

Atai Life Sciences

This biopharmaceutical company develops psychedelic and non-psychedelic therapies for patients living with mental health disorders, including depression, anxiety, and addiction.

GH Research

This pharmaceutical company develops psychedelic-based therapies for patients suffering from psychiatric and neurological disorders, including treatment-resistant depression.

ATAI

This biopharmaceutical company develops psychedelic-based treatments and mental health medicines for patients with neurological and psychiatric disorders, such as treatment-resistant depression and anxiety.

Enabling psychedelics-assisted therapies

This biopharmaceutical company develops psychedelic-inspired medicines and a care delivery model to treat addiction for patients and healthcare providers.

Psyon

This company provides psychedelic-assisted psychotherapy and psychiatric care to patients seeking treatment for mental health disorders.

Mycrodose Therapeutics

This pharmaceutical company develops advanced drug delivery systems for psychedelic and cannabinoid compounds to treat mental health and cognitive degenerative diseases.

Freedom Biosciences

The company develops ketamine and psychedelic therapeutics for patients suffering from treatment-resistant depression and other mental health conditions.

Helus Pharma

This pharmaceutical company develops serotonergic agonists and psychedelic medicines to treat patients with depression, anxiety and other mental health conditions.